| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8471776 | Immuno-analyse & Biologie Spécialisée | 2008 | 8 Pages |
Abstract
Follow-up by biological testing is now the standard of care for HIV infection. It is important for therapeutic decision-making when to start antiretroviral therapy in HIV patients or opportunists infection prevention. Viral load and CD4 counting permit to controlled efficiency treatment and tolerance. Drugs monitoring and resistance testing are routinely performed nowadays particularly in treatment failure. In the initial biological tests, experts recommended resistance testing and subtype determination to optimise antiretroviral treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
A. Greder Belan, C. Chaplain, A. Boussairi,